Inhibitors of Bcl-2 and Bruton’s tyrosine kinase synergize to abrogate diffuse large B-cell lymphoma growth in vitro and in orthotopic xenotransplantation models

Numerous targeted therapies have been developed for diffuse large B-cell lymphoma, but the results of late-stage clinical trials were mostly disappointing and have led to very few new regulatory approvals. Here, we use single and combinatorial drug response profiling to show that the combined inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertram, Katrin, Leary, Peter John, Boudesco, Christophe, Fullin, Jonas, Stirm, Kristin, Dalal, Vineet, Zenz, Thorsten, Tzankov, Alexandar, Müller, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979814/
https://www.ncbi.nlm.nih.gov/pubmed/34795418
http://dx.doi.org/10.1038/s41375-021-01470-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979814/
https://www.ncbi.nlm.nih.gov/pubmed/34795418
http://dx.doi.org/10.1038/s41375-021-01470-4

Ejemplares similares